Literature DB >> 27118067

Accuracy of computed tomographic angiography in the diagnosis of patients with inferior vena cava partial obstruction in Budd-Chiari syndrome.

Shi-Yi Liu1,2, Ping Xiao1, Hui-Cun Cao2, Hao-Sheng Jiang2, Tian-Xiao Li2.   

Abstract

BACKGROUND AND AIM: The diagnosis of the partially obstructed inferior vena cava (IVC) in Budd-Chiari syndrome (BCS) patients has received little attention. We aimed to evaluate the diagnostic accuracy of computed tomographic angiography (CTA) for patients with BCS and a partially obstructed IVC.
METHODS: A total of 329 patients with BCS and an obstructed IVC were endovascularly treated with balloon dilation and/or stent placement. All patients underwent a CTA examination prior to endovascular treatment, and the data were retrospectively reviewed. The presence of a round, oval, irregular shape or jet sign low-density area without enhancement within the enhanced proximal IVC was considered a sign of a partially obstructed IVC. Digital subtraction angiography was used as the gold standard.
RESULTS: The results from the digital subtraction angiography revealed a partially obstructed IVC in 108 BCS patients and a complete obstruction in 221 patients. The CTA discovered a partially obstructed IVC in 99 patients and a completely obstructed IVC in 230 patients. From the CTA results, 15 were false negatives, and six were false positives. The patient-based evaluation yielded an accuracy of 93.6%, a sensitivity of 86.1%, specificity of 97.3%, positive predictive value of 93.9%, and negative predictive value of 93.5% for the detection of BCS patients with a partial IVC obstruction.
CONCLUSIONS: Computed tomographic angiography offered a high diagnostic accuracy and sensitivity in BCS patients with a partially obstructed IVC. The low-density area within the enhanced proximal IVC above the membrane in artery phase can be considered a reliable indicator of a stenotic IVC in BCS patients.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Budd-Chiari syndrome (BCS); computed tomographic angiography (CTA); inferior vena cava (IVC); obstruction; venography

Mesh:

Year:  2016        PMID: 27118067     DOI: 10.1111/jgh.13420

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Diagnostic accuracy of magnetic resonance angiography for Budd-Chiari syndrome: A meta-analysis.

Authors:  Peng Xu; Lulu Lyu; Muhammad Umair Sami; Xin Lu; Haitao Ge; Yutao Rong; Chunfeng Hu; Kai Xu
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

2.  Evaluation of dangerous collateral vessels and thrombus in Budd-Chiari syndrome patients with inferior vena cava obstruction.

Authors:  Dehan Liu; Qianqian Ren; Tianhe Ye; Chuansheng Zheng; Yangbo Su; Xiangwen Xia
Journal:  Abdom Radiol (NY)       Date:  2021-12-09

Review 3.  Budd-Chiari syndrome: imaging review.

Authors:  Varun Bansal; Pankaj Gupta; Saroj Sinha; Narender Dhaka; Naveen Kalra; Rajesh Vijayvergiya; Usha Dutta; Rakesh Kochhar
Journal:  Br J Radiol       Date:  2018-07-24       Impact factor: 3.039

4.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

5.  Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis.

Authors:  Pankaj Gupta; Varun Bansal; Praveen Kumar-M; Saroj K Sinha; Jayanta Samanta; Harshal Mandavdhare; Vishal Sharma; Usha Dutta; Rakesh Kochhar
Journal:  Br J Radiol       Date:  2020-03-18       Impact factor: 3.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.